Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018224696) IN VITRO METHOD FOR THE DETERMINATION OF NEURODEGENERATIVE DISEASES
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/224696 International Application No.: PCT/EP2018/071542
Publication Date: 13.12.2018 International Filing Date: 08.08.2018
IPC:
G01N 33/68 (2006.01) ,G01N 33/558 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68
involving proteins, peptides or amino acids
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53
Immunoassay; Biospecific binding assay; Materials therefor
558
using diffusion or migration of antigen or antibody
Applicants:
SALION GMBH [DE/DE]; Sterzenweg 19 82541 Münsing, DE
Inventors:
STANGL, Manfred; DE
MARZINZIG, Michael; DE
ABENDROTH, Dietmar; DE
Agent:
WEICKMANN & WEICKMANN PARTMBB; Postfach 860 820 81635 München, DE
Priority Data:
17174895.708.06.2017EP
Title (EN) IN VITRO METHOD FOR THE DETERMINATION OF NEURODEGENERATIVE DISEASES
(FR) PROCÉDÉ IN VITRO DE DÉTERMINATION DE MALADIES NEURODÉGÉNÉRATIVES
Abstract:
(EN) The present invention concerns an in vitro method for the determination of a neurodegenerative disease wherein separately from each other the content of kynurenine and kynurenic acid in a body fluid is determined and the quotient of the content of kynurenine to the content of kynurenic acid is calculated.
(FR) La présente invention concerne un procédé in vitro de détermination d'une maladie neurodégénérative, les teneurs en kynurénine et en acide kynurénique dans un liquide corporel étant déterminées séparément l'une de l'autre et le quotient de la teneur en kynurénine sur la teneur en acide kynurénique étant calculé.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)